文献速递新发突发、热带与寄生虫病

通过考虑疟疾暴露异质性的新方法识别抗恶性疟原虫的保护性免疫相关指标

Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure.
PubMed 文献 · Clin Infect Dis · 2018-01-01

在莫桑比克儿童出生至3岁期间,用Luminex检测IgG/IgM及功能性抗体水平,并在9和24月龄建立Cox回归模型,分析时考虑疟疾暴露异质性或按抗体衰减限制随访。仅在24月龄儿童中发现针对EBA140III-V、CyRPA、DBL5ε和DBL3x的IgG广度与水平及靶向MSP119抗体的C1q固定活性与临床疟疾风险降低相关。

要点

  • 仅在24月龄儿童中发现保护性免疫相关指标,更年幼儿童中未发现。
  • 分析时考虑疟疾暴露异质性可避免将抗体反应错误关联为临床疟疾风险升高。
  • 按抗体衰减限制随访时间可避免抗体反应与临床疟疾风险升高的假性关联。

核心结论

  • 仅在24月龄儿童中、且分析时考虑疟疾暴露异质性时,识别出疟疾保护相关指标。
  • 结果强调需考虑年龄和疟疾暴露,且不应假设基线免疫反应在整个随访期间维持不变;若未考虑这些因素,结果可能产生误导。

研究设计与样本

  • 在莫桑比克儿童出生至3岁期间监测临床疟疾,用Luminex检测IgG/IgM水平及功能性抗体。
  • 研究的候选抗原包括红前期和红内期抗原,含EBAs/PfRhs、MSPs、DBLs及仅在或未曾在疟疾暴露人群中研究过的新抗原。
  • 在9和24月龄估计Cox回归模型,分析时考虑疟疾暴露异质性或按抗体衰减限制随访。

主要发现

  • 当分析时考虑疟疾暴露异质性或按抗体衰减限制随访时间,避免了抗体反应与更高临床疟疾风险的关联。
  • 仅在24月龄儿童(而非更年幼儿童)中发现,针对EBA140III-V、CyRPA、DBL5ε和DBL3x的IgG广度与IgG水平,以及靶向MSP119抗体的C1q固定活性,与临床疟疾风险降低相关。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: A main criterion to identify malaria vaccine candidates is the proof that acquired immunity against them is associated with protection from disease. The age of the studied individuals, heterogeneous malaria exposure, and assumption of the maintenance of a baseline immune response can confound these associations. METHODS: Immunoglobulin G/immunoglobulin M (IgG/ IgM) levels were measured by Luminex® in Mozambican children monitored for clinical malaria from birth until 3 years of age, together with functional antibodies. Studied candidates were pre-erythrocytic and erythrocytic antigens, including EBAs/PfRhs, MSPs, DBLs, and novel antigens merely or not previously studied in malaria-exposed populations. Cox regression models were estimated at 9 and 24 months of age, accounting for heterogeneous malaria exposure or limiting follow-up according to the antibody's decay. RESULTS: Associations of antibody responses with higher clinical malaria risk were avoided when accounting for heterogeneous malaria exposure or when limiting the follow-up time in the analyses. Associations with reduced risk of clinical malaria were found only at 24 months old, but not younger children, for IgG breadth and levels of IgG targeting EBA140III-V, CyRPA, DBL5ε and DBL3x, together with C1q-fixation activity by antibodies targeting MSP119. CONCLUSIONS: Malaria protection correlates were identified, only in children aged 24 months old when accounting for heterogeneous malaria exposure. These results highlight the relevance of considering age and malaria exposure, as well as the importance of not assuming the maintenance of a baseline immune response throughout the follow-up. Results may be misleading if these factors are not considered.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Valmaseda A, Macete E, Nhabomba A, et al. Identifying Immune Correlates of Protection Against Plasmodium falciparum Through a Novel Approach to Account for Heterogeneity in Malaria Exposure. Clin Infect Dis. 2018. PMID: 29401272. doi:10.1093/cid/cix837

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。